PDA

View Full Version : Novartis Highlights Advances for Patients With Breast Cancer and Hematological ... -



RetromanIE
02-12-2011, 07:41
<img alt="" height="1" width="1" />
Novartis Highlights Advances for Patients With Breast Cancer and Hematological ... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGhNa5durbhGY_QLx81VQJNM5mdmA&url=http://www.marketwatch.com/story/novartis-highlights-advances-for-patients-with-breast-cancer-and-hematological-diseases-with-over-160-sabcs-and-ash-abstracts-2011-12-02-12200)
MarketWatch (press release)
Afinitor is also approved in the US to treat patients with SEGA associated with TS who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of everolimus is based on an analysis of change in SEGA ...

and more &raquo; (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=dNkCEAV5JYcqNQM)


More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGhNa5durbhGY_QLx81VQJNM5mdmA&url=http://www.marketwatch.com/story/novartis-highlights-advances-for-patients-with-breast-cancer-and-hematological-diseases-with-over-160-sabcs-and-ash-abstracts-2011-12-02-12200)